Samuel Lentz MD
Gynecologic Oncology, Urogynecology & Pelvic Reconstructive Surgery
Professor of Obstetrics & Gynecology, Wake Forest University
Join to View Full Profile
500 Shepherd StWinston Salem, NC 27103
Phone+1 336-716-2255
Dr. Lentz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Obstetrics and Gynecology, 1986 - 1989
- Wake Forest University Baptist Medical CenterInternship, Transitional Year, 1978 - 1979
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1978
Certifications & Licensure
- NC State Medical License 1979 - 2025
- MN State Medical License 1986 - 1989
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Female Pelvic Medicine and Reconstructive Surgery
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2018
- America's Top Doctors for Cancer Castle Connolly, 2005-2018
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
- Join now to see all
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
- Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
- Join now to see all
Publications & Presentations
PubMed
- Transvaginal ureteroneocystostomy.Laurel K Berry, Collin M McKenzie, Samuel S Lentz
Urology Case Reports. 2023-11-01 - 6 citationsThe clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary study.John K Chan, Chunqiao Tian, Joshua P Kesterson, Michael T Richardson, Ken Lin
Gynecologic Oncology. 2022-12-01 - 2 citationsHIPEC after neoadjuvant chemotherapy is associated with acceptable toxicity and favorable quality of life in newly diagnosed advanced ovarian cancer patients.Anya V Menzies, Erik C Usher, Fang-Chi Hsu, Edward A Levine, Samuel S Lentz
Gynecologic Oncology. 2022-11-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
